Firms

Aulis Capital

Aulis Capital

auliscapital.com

Aulis Capital invests in early and growth-stage healthcare companies, including biotechnology, medical devices, diagnostics and digital health. It combines scientific and investment expertise with partnerships across Asia and global healthcare markets to help companies develop therapies, validate products, and expand internationally. Its published team includes healthcare investors and operating specialists, and its investments include EpiBiologics’ extracellular protein-degradation platform.

Founded
—
Type
Venture capital

Funds1

  • Aulis Capital Fund I, LP—

    Aulis Capital’s Cayman Islands venture capital fund disclosed its initial Form D offering on December 18, 2025. The filing reported an indefinite total offering, zero sold, zero investors and first sale yet to occur. Fund commitments and a final close are not verified, so numeric size remains unknown. The SEC submissions record checked October7,2026 lists only this initial filing for CIK2099709. Fund formation in2025 is distinct from first sale or final close.

Team

Operations and support

Alwin PoonVenture Partner
Ethan ThanVenture Partner
Franck Le DeuVenture Partner
Grace NgChief Financial Officer
Lingshi TanVenture Partner
Mingyu XuePrincipal
Nisa LeungFounding Managing Partner
Paul LiVenture Partner

Co-investing

Investments